Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.
NCT ID: NCT04070885
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
210 participants
OBSERVATIONAL
2011-01-05
2015-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Influencing Risk of Progression of Chronic Kidney Disease
NCT03954470
Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06495385
Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression
NCT00608998
Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1)
NCT07288723
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease
NCT06962891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is necessary to know better:
* the mechanisms leading to the progression of the Chronic Renal Diseases
* markers to quantify renal function and progression of the Chronic Renal Diseases
* the pathophysiology of Chronic Renal Diseases complications, cardiovascular, nutritional, or mineral metabolism in particular.
This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
A dry tube of 7 ml of blood, two 4 ml EDTA tubes, a 4 ml heparinized tube and an 8.5 ml ACD-A tube will be collected from the patient.
Urine sample
The urine will be taken from three 15 ml tubes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* followed in the Nephrology Department of the Bordeaux University Hospital
* agreeing to participate in NephroTest
* affiliated with social security.
Exclusion Criteria
* Patients with acute or rapidly progressive renal failure
* Patients with severe comorbidities or comorbidities that are life-threatening in the short term (\<1 year)
* Patients who did not give their written consent to be included in the study
* Major incapacitated patients and psychiatric patients admitted to hospital
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian COMBE, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2009/29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.